These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32631179)

  • 41. 'Acute-on-chronic': Emergency Affect and the One-way Staircase of Pharmaceutical Escalation.
    Stonington SD
    Med Anthropol; 2021 Apr; 40(3):228-240. PubMed ID: 32886015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioids, pain management and the law.
    Stayner RS; Copenhaver DJ
    Curr Opin Anaesthesiol; 2012 Oct; 25(5):566-71. PubMed ID: 22914352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A crisis of opioids and the limits of prescription control: United States.
    Kertesz SG; Gordon AJ
    Addiction; 2019 Jan; 114(1):169-180. PubMed ID: 30039595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "My life is under control with these medications": an interpretative phenomenological analysis of managing chronic pain with opioids.
    Ljungvall H; Rhodin A; Wagner S; Zetterberg H; Åsenlöf P
    BMC Musculoskelet Disord; 2020 Jan; 21(1):61. PubMed ID: 32005212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management.
    Dorflinger L; Moore B; Goulet J; Becker W; Heapy AA; Sellinger JJ; Kerns RD
    J Gen Intern Med; 2014 Dec; 29 Suppl 4(Suppl 4):870-6. PubMed ID: 25355083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Country in Crisis: Opioid Sparing Solutions for Acute Pain Management.
    LaPietra AM; Motov S
    Mo Med; 2019; 116(2):140-145. PubMed ID: 31040501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Managing twin crises in chronic pain and prescription opioids.
    Mackey S; Kao MC
    BMJ; 2019 Mar; 364():l917. PubMed ID: 30842099
    [No Abstract]   [Full Text] [Related]  

  • 48. Restoring balance to cancer pain management.
    Cleary JF
    Cancer; 2020 Feb; 126(4):697-700. PubMed ID: 31846053
    [No Abstract]   [Full Text] [Related]  

  • 49. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report.
    Kroenke K; Alford DP; Argoff C; Canlas B; Covington E; Frank JW; Haake KJ; Hanling S; Hooten WM; Kertesz SG; Kravitz RL; Krebs EE; Stanos SP; Sullivan M
    Pain Med; 2019 Apr; 20(4):724-735. PubMed ID: 30690556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients.
    Daitch D; Daitch J; Novinson D; Frey M; Mitnick C; Pergolizzi J
    Pain Med; 2014 Dec; 15(12):2087-94. PubMed ID: 25220043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. JAMA PATIENT PAGE. Opioids for Chronic Pain.
    Cordier Scott L; Lewis S
    JAMA; 2016 Apr; 315(15):1672. PubMed ID: 26978825
    [No Abstract]   [Full Text] [Related]  

  • 52. Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain.
    Busse JW; Juurlink D; Guyatt GH
    CMAJ; 2016 Dec; 188(17-18):1210-1211. PubMed ID: 27873754
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain.
    Miller GF; Guy GP; Zhang K; Mikosz CA; Xu L
    Pain Med; 2019 Oct; 20(10):1948-1954. PubMed ID: 30481359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015.
    Shah A; Hayes CJ; Martin BC
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(10):265-269. PubMed ID: 28301454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.
    Rauck RL
    Pain Pract; 2019 Apr; 19(4):443-454. PubMed ID: 30597739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused?
    Pergolizzi JV; Raffa RB; LeQuang JA
    J Clin Pharm Ther; 2016 Dec; 41(6):592-593. PubMed ID: 27576604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
    Webster LR; Markman J; Cone EJ; Niebler G
    Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Strengths and Weaknesses of Current US Policy to Address Pain.
    Gross J; Gordon DB
    Am J Public Health; 2019 Jan; 109(1):66-72. PubMed ID: 30495994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drivers, Beliefs, and Barriers Surrounding Surgical Opioid Prescribing: A Qualitative Study of Surgeons' Opioid Prescribing Habits.
    Sceats LA; Ayakta N; Merrell SB; Kin C
    J Surg Res; 2020 Mar; 247():86-94. PubMed ID: 31767277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.
    Sanger N; Bhatt M; Shams I; Shahid H; Luo C; Tam SL; Samaan MC; de Souza R; Thabane L; Samaan Z
    Pain Physician; 2018 Nov; 21(6):E623-E632. PubMed ID: 30508993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.